Covered recipient · General Payments record
RALEIGH CUTRER
General Payments · PY2018–2024
$4,785.75
- Reported across 186 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,381.71 | 55 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $500.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $500.00 | 1 |
| GlaxoSmithKline, LLC. | $166.29 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $150.39 | 6 |
| ABBVIE INC. | $102.54 | 2 |
| PFIZER INC. | $85.37 | 5 |
| Celgene Corporation | $83.83 | 4 |
| Merck Sharp & Dohme Corporation | $77.14 | 3 |
| Astellas Pharma US Inc | $73.77 | 4 |
| Janssen Biotech, Inc. | $73.44 | 3 |
| Daiichi Sankyo Inc. | $68.37 | 3 |
| Lilly USA, LLC | $53.76 | 3 |
| AVEO Pharmaceuticals, Inc. | $41.02 | 1 |
| BeiGene USA, Inc. | $39.94 | 2 |
| Deciphera Pharmaceuticals Inc. | $39.73 | 2 |
| Acerta Pharma LLC | $34.36 | 1 |
| Ipsen Biopharmaceuticals, Inc | $32.75 | 1 |
| Tempus AI, Inc | $29.44 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.04 | 1 |
| Kite Pharma, Inc. | $24.61 | 1 |
| EISAI INC. | $24.53 | 1 |
| Genmab U.S., Inc. | $24.01 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.74 | 1 |
| Incyte Corporation | $19.57 | 1 |
| Immunocore Limited | $18.73 | 1 |
| Blueprint Medicines Corporation | $18.66 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.07 | 1 |
| Myriad Genetic Laboratories, Inc. | $16.81 | 1 |
| Acrotech Biopharma Inc. | $16.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (56)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.